Substance / Medication

Naftifine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
Stein Gold Linda F, Vlahovic Tracey, Verma Amit et al. · J Drugs Dermatol · 2015
PMID: 26461826Meta-Analysis
Transdermal platform for the delivery of the antifungal drug naftifine hydrochloride based on porous vaterite particles.
Gusliakova Olga, Verkhovskii Roman, Abalymov Anatolii et al. · Mater Sci Eng C Mater Biol Appl · 2021
PMID: 33321579Other
In vitro antifungal activity of naftifine hydrochloride against dermatophytes.
Ghannoum M, Isham N, Verma A et al. · Antimicrob Agents Chemother · 2013
PMID: 23817365OtherFull text (PMC)
Development of naftifine hydrochloride alcohol-free niosome gel.
Barakat Heba S, Darwish Inas A, El-Khordagui Labiba K et al. · Drug Dev Ind Pharm · 2009
PMID: 18989805Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Naftifine hydrochloride (substance)
SNOMED CT
47408003
UMLS CUI
C0304594

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.